Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $8.0000 (0.25%) ($7.9100 - $8.3000) on Fri. Nov. 15, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.9% (three month average) | RSI | 74 | Latest Price | $8.0000(0.25%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -0.4% a day on average for past five trading days. | Weekly Trend | TGTX advances 6.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(65%) ARKG(58%) IBB(57%) ARKK(56%) IWO(56%) | Factors Impacting TGTX price | TGTX will decline at least -1.95% in a week (0% probabilities). VIXM(-40%) VXX(-38%) UUP(-7%) TLT(-7%) IGOV(-1%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.95% (StdDev 3.9%) | Hourly BBV | 0 () | Intraday Trend | -0.9% | | | |
|
5 Day Moving Average | $7.85(1.91%) | 10 Day Moving Average | $7.78(2.83%) | 20 Day Moving Average | $7.07(13.15%) | To recent high | -2.1% | To recent low | 56.9% | Market Cap | $1.013b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |